• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利什曼原虫主要表面糖蛋白(gp63)宿主保护性T细胞表位的鉴定与特性分析

Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major.

作者信息

Yang D M, Rogers M V, Liew F Y

机构信息

Department of Experimental Immunobiology, Wellcome Biotech, Beckenham, Kent, U.K.

出版信息

Immunology. 1991 Jan;72(1):3-9.

PMID:1997399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1384327/
Abstract

By using a series of overlapping synthetic peptides that cover more than 75% of the amino acid sequence of the major surface glycoprotein (gp63) from Leishmania major, 11 T-cell epitopes in CBA and BALB/c mice have been identified. Six of the peptides were recognized by T cells of CBA mice recovered from L. major infection, while one was recognized by the T cells from BALB/c mice recovered from the infection following sublethal doses of gamma-irradiation. Lymph node cells from mice immunized with the peptides also responded to a number of the same peptides (seven in CBA and one in BALB/c). Peptide p10-28 induced proliferative T-cell responses in both CBA and BALB/c mice. Five of the peptides (p10-28, p22-40, p289-309, p459-471 and p467-482) induced vigorous T-cell response in CBA mice but were not recognized by T cells from recovered mice. Four other peptides (p321-336, p364-476, p372-385 and p378-396) were recognized by T cells from recovered CBA mice but could not induce a T-cell response in normal CBA mice. Three peptides (p146-171, p289-309 and p395-414) were both able to induce a T-cell response and were recognized by T cells from recovered mice. However, only two peptides (p146-171 and p467-482) were able to activate T cells, which also recognized epitopes expressed by antigen-presenting cells infected with promastigotes. T cells induced by p146-171 and p467-171 or a mixture of these two peptides were mainly CD4+ and produced interleukin (IL-2) and interferon-gamma (IFN-gamma) but not IL-4 upon antigen stimulation in vitro. These two peptides also induced a classical delayed type hypersensitivity (DTH) response in CBA mice. Furthermore, CBA mice immunized with a mixture of the two peptides in Coryne parvum or entrapped in liposomes induced significant resistance against L. major infection. The implications of these results in terms of a synthetic vaccine against leishmaniasis and the mechanism of the induction of Th1 and Th2 cells are discussed.

摘要

通过使用一系列覆盖来自硕大利什曼原虫主要表面糖蛋白(gp63)超过75%氨基酸序列的重叠合成肽,已在CBA和BALB/c小鼠中鉴定出11个T细胞表位。其中6个肽被从硕大利什曼原虫感染中恢复的CBA小鼠的T细胞识别,而1个肽被经亚致死剂量γ射线照射后从感染中恢复的BALB/c小鼠的T细胞识别。用这些肽免疫的小鼠的淋巴结细胞也对许多相同的肽产生反应(CBA小鼠中有7个,BALB/c小鼠中有1个)。肽p10 - 28在CBA和BALB/c小鼠中均诱导了增殖性T细胞反应。其中5个肽(p10 - 28、p22 - 40、p289 - 309、p459 - 471和p467 - 482)在CBA小鼠中诱导了强烈的T细胞反应,但未被恢复小鼠的T细胞识别。另外4个肽(p321 - 336、p364 - 476、p372 - 385和p378 - 396)被从感染中恢复的CBA小鼠的T细胞识别,但在正常CBA小鼠中不能诱导T细胞反应。3个肽(p146 - 171、p289 - 309和p395 - 414)既能诱导T细胞反应,又能被恢复小鼠的T细胞识别。然而,只有2个肽(p146 - 171和p467 - 482)能够激活T细胞,这些T细胞也识别被前鞭毛体感染的抗原呈递细胞所表达的表位。由p146 - 171和p467 - 171或这两种肽的混合物诱导的T细胞主要是CD4 + ,在体外抗原刺激下产生白细胞介素(IL - 2)和干扰素 - γ(IFN - γ),但不产生IL - 4。这两种肽在CBA小鼠中也诱导了典型的迟发型超敏反应(DTH)。此外,用这两种肽的混合物在短小棒状杆菌中或包裹在脂质体中免疫的CBA小鼠对硕大利什曼原虫感染产生了显著的抵抗力。讨论了这些结果对于抗利什曼病合成疫苗的意义以及Th1和Th2细胞诱导机制。

相似文献

1
Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major.利什曼原虫主要表面糖蛋白(gp63)宿主保护性T细胞表位的鉴定与特性分析
Immunology. 1991 Jan;72(1):3-9.
2
Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.
J Immunol. 1990 Oct 1;145(7):2281-5.
3
Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-).通过口服减毒鼠伤寒沙门氏菌(AroA - AroD -)递送的gp63对基因易感的BALB/c小鼠进行利什曼原虫主要感染的保护。
Immunology. 1995 May;85(1):1-7.
4
Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.与具有抗性的CBA小鼠相比,易感性BALB/c小鼠中利什曼原虫主要特异性L3T4 + T细胞的频率更高。
J Immunol. 1986 Feb 15;136(4):1467-71.
5
Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.小鼠利什曼病中的免疫调节途径:墨西哥利什曼原虫和硕大利什曼原虫感染期间的不同调节控制
Clin Exp Immunol. 1985 Sep;61(3):674-82.
6
Vaccination of the Leishmania major susceptible BALB/c mouse. I. The precise selection of peptide determinant influences CD4+ T cell subset expression.对利什曼原虫主要易感的BALB/c小鼠进行疫苗接种。I. 肽决定簇的精确选择影响CD4+ T细胞亚群的表达。
Int Immunol. 1994 May;6(5):785-94. doi: 10.1093/intimm/6.5.785.
7
Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.从大型利什曼原虫感染中恢复或经皮下用灭活寄生虫免疫后,基因易感的BALB/c小鼠具有独特的细胞免疫。
J Immunol. 1987 Jun 15;138(12):4450-6.
8
A repetitive peptide of Leishmania can activate T helper type 2 cells and enhance disease progression.利什曼原虫的一种重复肽可激活2型辅助性T细胞并促进疾病进展。
J Exp Med. 1990 Nov 1;172(5):1359-65. doi: 10.1084/jem.172.5.1359.
9
Leishmania major: production of recombinant gp63, its antigenicity and immunogenicity in mice.硕大利什曼原虫:重组糖蛋白63的产生、其在小鼠中的抗原性和免疫原性
Exp Parasitol. 1990 May;70(4):427-35. doi: 10.1016/0014-4894(90)90127-x.
10
Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.小鼠皮肤利什曼病:抵抗力与体外对利什曼原虫抗原产生γ干扰素的能力相关。
J Immunol. 1986 Jan;136(2):655-61.

引用本文的文献

1
Prediction of an immunogenic peptide ensemble and multi-subunit vaccine for Visceral leishmaniasis using bioinformatics approaches.利用生物信息学方法预测内脏利什曼病的免疫原性肽组和多亚基疫苗。
Heliyon. 2023 Nov 14;9(12):e22121. doi: 10.1016/j.heliyon.2023.e22121. eCollection 2023 Dec.
2
Peptide Vaccines for Leishmaniasis.利什曼病的肽疫苗。
Front Immunol. 2018 May 11;9:1043. doi: 10.3389/fimmu.2018.01043. eCollection 2018.
3
Effector/memory CD4 T cells making either Th1 or Th2 cytokines commonly co-express T-bet and GATA-3.产生Th1或Th2细胞因子的效应/记忆CD4 T细胞通常共表达T-bet和GATA-3。
PLoS One. 2017 Oct 31;12(10):e0185932. doi: 10.1371/journal.pone.0185932. eCollection 2017.
4
Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.内脏利什曼病:通过经典和分子方法在疫苗开发方面的进展。
Front Immunol. 2014 Aug 22;5:380. doi: 10.3389/fimmu.2014.00380. eCollection 2014.
5
Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines.基于计算机预测的利什曼原虫候选肽疫苗的免疫原性和免疫调节作用。
Hum Vaccin Immunother. 2012 Dec 1;8(12):1769-74. doi: 10.4161/hv.21881. Epub 2012 Aug 24.
6
The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.刚地弓形虫肽 AS15 能诱导产生可控制寄生虫负荷的 CD4 T 细胞。
Infect Immun. 2012 Sep;80(9):3279-88. doi: 10.1128/IAI.00425-12. Epub 2012 Jul 9.
7
Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model.针对内脏利什曼病的单抗原 Gp63、多表位和多表位 HSP70 DNA 疫苗的免疫原性和疗效的实验性小鼠模型研究。
PLoS One. 2009 Dec 2;4(12):e7880. doi: 10.1371/journal.pone.0007880.
8
Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice.利什曼原虫杜氏亚种抗原包裹于脂质体中的特性研究,该脂质体可在BALB/c小鼠中诱导保护性免疫。
Infect Immun. 2002 Dec;70(12):6697-706. doi: 10.1128/IAI.70.12.6697-6706.2002.
9
Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.基于细菌脂蛋白的疫苗可诱导针对硕大利什曼原虫的肿瘤坏死因子依赖性1型保护性免疫。
Infect Immun. 2002 Jan;70(1):240-8. doi: 10.1128/IAI.70.1.240-248.2002.
10
Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8.保护性皮氏利什曼原虫无鞭毛体抗原P-8的生化及生物学特性
Infect Immun. 2001 Nov;69(11):6776-84. doi: 10.1128/IAI.69.11.6776-6784.2001.

本文引用的文献

1
The promastigote surface protease of Leishmania.利什曼原虫前鞭毛体表面蛋白酶
Parasitol Today. 1987 May;3(5):151-3. doi: 10.1016/0169-4758(87)90199-2.
2
A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana.一种经辐射减毒的硕大利什曼原虫疫苗显著增强了CBA小鼠对随后感染墨西哥利什曼原虫墨西哥亚种的抵抗力。
Trans R Soc Trop Med Hyg. 1982;76(5):646-9. doi: 10.1016/0035-9203(82)90232-2.
3
Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.针对实验性利什曼病的预防性免疫:I. 在对热带利什曼原虫致命感染具有遗传易感性的小鼠中诱导的保护作用。
J Immunol. 1982 Nov;129(5):2206-12.
4
Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.热带利什曼原虫(硕大利什曼原虫)感染小鼠:对高遗传易感性小鼠进行皮肤利什曼病疫苗接种。
Aust J Exp Biol Med Sci. 1983 Feb;61(Pt 1):11-25. doi: 10.1038/icb.1983.2.
5
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.通过体内消除T细胞亚群进行单克隆抗体治疗。
Nature. 1984;312(5994):548-51. doi: 10.1038/312548a0.
6
The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages.利什曼原虫前鞭毛体的主要表面糖蛋白(gp63)在与巨噬细胞附着中的作用。
J Immunol. 1986 Apr 1;136(7):2613-20.
7
Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis.巨噬细胞利什曼原虫受体免疫可保护小鼠免受皮肤利什曼病感染。
Proc Natl Acad Sci U S A. 1985 Sep;82(17):5910-4. doi: 10.1073/pnas.82.17.5910.
8
Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.鼠模型中皮肤利什曼病的疫苗接种。I. 前鞭毛体可溶性提取物诱导保护性免疫
J Immunol. 1987 Jul 1;139(1):221-7.
9
Molecular cloning of the major surface antigen of leishmania.利什曼原虫主要表面抗原的分子克隆
J Exp Med. 1988 Feb 1;167(2):724-9. doi: 10.1084/jem.167.2.724.
10
Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.用重组到脂质体中的特定膜抗原对皮肤利什曼病进行有效免疫。
J Immunol. 1988 Feb 15;140(4):1274-9.